A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol

BACKGROUND: Since the development of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy (IMRT), no prospective study has investigated whether concurrent chemoradiotherapy (SIB-IMRT with 60 Gy) remains superior to radiotherapy (SIB-IMRT) alone for unresectable esophageal ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Lin-rui, Wang, Xin, Han, Weiming, Deng, Wei, Li, Chen, Wang, Xiaomin, Zhao, Yidian, Ni, Wenjie, Chang, Xiao, Zhou, Zongmei, Deng, Lei, Wang, Wenqing, Liu, Wenyang, Liang, Jun, Zhang, Tao, Bi, Nan, Wang, Jianyang, Zhai, Yirui, Feng, Qinfu, Lv, Jima, Li, Ling, Xiao, Zefen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510301/
https://www.ncbi.nlm.nih.gov/pubmed/32962674
http://dx.doi.org/10.1186/s12885-020-07387-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510301/
https://www.ncbi.nlm.nih.gov/pubmed/32962674
http://dx.doi.org/10.1186/s12885-020-07387-y

Ejemplares similares